EUROIMMUN Anti-SARS-CoV-2 S1 Curve ELISA Receives FDA Emergency Use Authorization

Assay enabling the measurement of IgG antibodies could yield future discoveries and insights on immune responses to SARS-CoV-2 WALTHAM, Mass. –(BUSINESS WIRE)–Oct. 5, 2021– EUROIMMUN , a PerkinElmer, Inc. company (NYSE: PKI), announced today that the U.S.


Get every new post delivered right to your inbox.

Original Source